[Antibacterial effect of sulfanilamide combination drugs].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004338:Drug Combinations; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D013420:Sulfamethoxazole / Q000494:pharmacology*; D013424:Sulfanilamides / Q000494:pharmacology*; D014295:Trimethoprim / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D011804:Quinolines; D013424:Sulfanilamides; D014295:Trimethoprim; D013420:Sulfamethoxazole
Die antibakterielle Wirkung von Sulfanilamid-Kombinationspräparaten.